Molnupiravir is expensive and pathetic, especially when compared against vitamin D: 2022 confirms 2021
New research proves that I was right a year ago
In 2022, new data again shows that Molnupiravir is pathetic
In 2021, HealthyThinking subscribers knew first
Subscribers to my newsletter were the first (Oct2022)to see that Molnupiravir was a waste of money, and that vitamin D was superior.
The data on Merck’s molnupiravir was pathetic from the start, but America’s bribed politicians spent $$$BILLION on it anyway; by that same time (from Oct2022), the data on the benefits of vitamin D was already clear:
